Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2024-10-11 | Amended | $17,764,699 | $9,033,438 | Equity Only | 06b | SEC link |
| 2023-10-12 | New | $8,731,261 | $8,731,261 | Equity Only | 06b | SEC link |
| 2020-12-23 | New | $1,850,000 | $1,850,000 | Equity and Debt | 06b | SEC link |
| 2019-10-22 | New | $4,000,000 | $4,000,000 | Equity and Debt | 06b | SEC link |
| 2018-05-18 | New | $2,210,527 | $2,210,527 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Gregory Bailey | Director |
| Justin Briggs | Director |
| Steve Felstead | Director |
| Paulo Fontes | Executive |
| Michael Hufford | Director, Executive, Promoter |
| Eric Lagasse | Director, Executive |
| Eric Legasse | Executive, Promoter |
| James Mellon | Director |